MedTrace Logo

Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury

NCT01430988 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 318

Last updated 2012-05-03

No results posted yet for this study

Summary

The purpose of the current study is proposed to prospectively assess how accurately the BrainScope® Ahead™ M-100 can distinguish risk categories for acute head injury.

Conditions

  • Brain Injuries
  • Craniocerebral Trauma

Sponsors & Collaborators

  • BrainScope Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Rupert Pearse, MD · Royal London Hospital, Barts and The London School of Medicine and Dentistry

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01430988 on ClinicalTrials.gov